Modulus is engineering next-generation immune cell therapies, starting with Natural Killer cells rationally designed for the treatment of solid tumors. Modulus’ Convergent Design™ platform combines genetic engineering, machine learning, and high-throughput in vivo screening to systematically converge on optimized cell designs. Modulus is committed to the discovery of cell therapies to treat a broad set of patient populations not currently served by existing treatments and will use its platform to enable partners and develop an internal pipeline of therapeutics.
| Website | http://www.modulustherapeutics.com |
| Employees | View employees |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Immune Cell Therapy, Cell Therapy, Solid Tumor Treatment, Immuno-Oncology, Immunotherapy, Cancer Treatment, Cancer Immunotherapy, Cancer Research, Oncology Therapeutics, Targeted Therapy, Therapeutic Platform, Genetic Engineering, Precision Medicine, Biotechnology, Machine Learning, Drug Development, Pharmaceutical, Clinical Trials |
| Competitors | Sanofi, AstraZeneca, Regeneron, Moderna Therapeutics, Vir Biotechnology, Inc., CureVac, INOVIO Pharmaceuticals, Inc., RaNA Therapeutics, Pipeline Therapeutics, TARIS Bio +28 more (view full list) |
Looking for a particular Modulus Therapeutics employee's phone or email?
Modulus Therapeutics Questions
Modulus Therapeutics is based in Seattle, Washington.
Related Companies
